Benzazepines and benzodiazepines
Benzazepines and benzodiazepines is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Benzodiazepine
Benzodiazepine is under investigation for the prevention of Delirium and C.Surgical Procedure; Cardiac. Benzodiazepine has been investigated for the treatment of Obesity, Sleep Apnea, Obstructive, and Disorders of Gallbladder, Biliary Tract and Pancrease. — DrugBank
- IUPAC name
- 1H-1,2-benzodiazepine
- Molecular formula
- C9H8N2
- Molecular weight
- 144.17 g/mol
- Exact mass
- 144.068748264 Da
- XLogP3
- 1.9
- Topological polar surface area
- 24.4 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
5 more reported names
External database identifiers
Evidence from additional scientific databases
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record
Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.
Additional source coverage and match status
| Source | Result | Checked |
|---|---|---|
| NIH PubChem PUG-View | Exact match | 2026-08-31 |
A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Benzazepines and benzodiazepines
Regulatory information
Key data
Related records for Benzazepines and benzodiazepines
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
1-Dimethylaminomethyl-1-methylpropyl benzoate (amylocaine) and its salts
2,2,6-Trimethyl-4-piperidyl benzoate (eucaine) and its salts
Barium salts, with the exception of barium sulphide under the conditions laid down in Annex III and…
Atropine, its salts and derivatives
Bendroflumethiazide (INN) and its derivatives
Atropa belladonna L. and its preparations
What Annex II means for Benzazepines and benzodiazepines
Benzazepines and benzodiazepines is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Benzazepines and benzodiazepines
This page summarizes one Annex II record for Benzazepines and benzodiazepines from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Benzazepines and benzodiazepines, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Benzazepines and benzodiazepines and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Benzazepines and benzodiazepines side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II